Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical pharmacology 2013-04, Vol.69 (4), p.1037-1039
Hauptverfasser:	Desaphy, Jean-François, Modoni, Anna, LoMonaco, Mauro, Camerino, Diana Conte
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Biomedical and Life Sciences Biomedicine Diseases of striated muscles. Neuromuscular diseases Female Flecainide - administration & dosage Flecainide - therapeutic use Humans Letter to the Editors Male Medical sciences Mutation Myotonia Congenita - drug therapy Myotonia Congenita - genetics NAV1.4 Voltage-Gated Sodium Channel - genetics Neurology Nuclear Family Pharmacogenetics Pharmacology. Drug treatments Pharmacology/Toxicology Treatment Outcome Voltage-Gated Sodium Channel Blockers - administration & dosage Voltage-Gated Sodium Channel Blockers - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!